Myasthenogenicity of the main immunogenic region

Annals of the New York Academy of Sciences

Volumn 1274, Issue 1, 2012, Pages 9-13

  Lindstrom, Jon ^a   Luo, Jie ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AChR; Antigenic structure; EAMG; MG; Nicotinic acetylcholine receptor

Indexed keywords

NICOTINIC RECEPTOR;

ALPHA 1 MAIN IMMUNOGENIC REGION; ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; GENE SEQUENCE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; MYASTHENIA GRAVIS; NONHUMAN; PROTEIN STRUCTURE;

EID: 84871332667     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06766.x     Document Type: Article

References (17)

1. Tzartos, S. & J. Lindstrom. 1980. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc. Natl. Acad. Sci. USA 77: 755-759.
2. Lindstrom, J. 2000. Acetylcholine receptors and myasthenia. Muscle Nerve 23: 453-477.
3. Luo, J., P. Taylor, M. Losen, et al. 2009. Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity. J. Neurosci. 29: 13898-13908.
4. Unwin, N. 2005. Refined structure of the nicotinic acetylcholine receptor at 4Å resolution. J. Mol. Biol. 346: 967-989.
5. Brejc, K., W. van Dyk, R. Klassen, et al. 2001. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411: 269-276.
6. Hansen, S., G. Sulzenbacher, T. Huxford, et al. 2005. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J. 24: 3635-3646.
7. Kontou, M., D. Leonidas, E. Vatzaki, et al. 2000. The crystal structure of the Fab fragment of a rat monoclonal antibody against the main immunogenic region of the human muscle acetylcholine receptor. Eur. J. Biochem. 267: 2389-2397.
8. Delisanti, C., Y. Yao, J. Stroud, et al. 2007. Crystal structure of the extracellular domain of nAChR α1 bound to αbungarotoxin at 1.94 Å resolution. Nature Neurosci. 10: 953-962.
9. Millar, N. 2008. RIC-3: a nicotinic acetylcholine receptor chaperone. Brit. J. Pharmacol. 153: S177-S183.
10. Castillo, M., J. Mulet, M. Aldea, et al. 2009. Role of the N-terminal α helix in biogenesis of α7 nicotinic receptors. J. Neurochem. 108: 1399-1409.
11. Engel, A.G., X.M. Shen, D. Selcen & S.M. Sine. 2010. What we have learned from congenital myasthenic syndromes. J. Mol. Neuroscience 40: 143-153.
12. Lindstrom, J., B. Einarson & J. Merlie. 1978. Immunization of rats with polypeptide chains from Torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle. Proc. Natl. Acad. Sci. USA 75: 769-773.
13. Luo, J. & J. Lindstrom. 2012. Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors. Autoimmunity 45: 245-252.
14. Feferman, T., S.H. Im, S. Fuchs & M.C. Souroujon. 2003. Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis. J. Neuroimmunol. 140: 153-158.
15. Lindstrom, J., V. Lennon, M. Seybold & S. Whittingham. 1976. Experimental autoimmune myasthenia gravis and myastheniagravis: biochemical and immunochemical aspects. Ann. N. Y. Acad. Sci. 274: 254-274.
16. Luo, J., A. Kuryatov & J. Lindstrom. 2010. Specific immunotherapy of experimental myasthenia gravis by a novel mechanism. Ann. Neurology 67: 441-451.
17. Vernino, S., J. Lindstrom, S. Hopkins, et al. 2008. Characterization of ganglionic acetylcholine receptor autoantibodies. J. Neuroimmunology 197: 63-69.